Anti-LATS1/WARTS antibody
4
(1 Review)
|
(34 Publications)
Rabbit Polyclonal LATS1/WARTS antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human LATS1 aa 50-100.
View Alternative Names
WARTS, LATS1, Serine/threonine-protein kinase LATS1, Large tumor suppressor homolog 1, WARTS protein kinase, h-warts
- IP
Unknown
Immunoprecipitation - Anti-LATS1/WARTS antibody (AB70561)
Detection of human LATS1/WARTS by Immunoprecipitation in whole cell lysate from HeLa cells (1 mg, 1/4 of immunoprecipitate loaded/lane), using ab70561 at 3 μg/mg of lysate (lane 1).
LATS1/WARTS was also immunoprecipitated with an other LATS1/WARTS antibody (lanes 2) and with ab70562 (lane 3) using 3 μg/mg lysate.
Lane 4 : Control IgG immunoprecipitate.
Subsequent Western blot detection of LATS1/WARTS was performed using ab70561 at 0.1 μg/ml.
All lanes:
Immunoprecipitation - Anti-LATS1/WARTS antibody (ab70561)
Predicted band size: 126 kDa
false
- WB
Unknown
Western blot - Anti-LATS1/WARTS antibody (AB70561)
All lanes:
Western blot - Anti-LATS1/WARTS antibody (ab70561) at 0.02 µg/mL
Lane 1:
Whole cell lysate from Hela cells at 50 µg
Lane 2:
Whole cell lysate from Hela cells at 15 µg
Predicted band size: 126 kDa
Observed band size: 117 kDa,160 kDa,200 kDa,268 kDa,71 kDa
false
- WB
Supplier Data
Western blot - Anti-LATS1/WARTS antibody (AB70561)
All lanes:
Western blot - Anti-LATS1/WARTS antibody (ab70561) at 0.2 µg/mL
Lane 1:
CT26.WT whole cell lysate at 50 µg
Lane 2:
TCMK-1 whole cell lysate at 50 µg
Predicted band size: 126 kDa
false
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LATS1/WARTS functions as an important regulator of cellular growth and differentiation. It is part of the Hippo signaling complex which includes proteins like MST1/2 and YAP/TAZ. This complex helps maintain proper tissue homeostasis by modulating gene expression in response to cellular density and mechanical cues. In doing so LATS1/WARTS phosphorylates and inactivates downstream effectors YAP and TAZ preventing them from translocating to the nucleus where they could promote transcription of growth-promoting genes.
Pathways
Scientists have found LATS1/WARTS to be integral to both the Hippo signaling pathway and the cell cycle regulation pathway. Within these pathways LATS1/WARTS interacts closely with proteins such as MOB1 and YAP mediating cellular responses to growth inhibitory signals. By controlling these interactions LATS1/WARTS helps coordinate cell proliferation and apoptosis which is critical for proper developmental processes and prevention of tumor growth.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (34)
Recent publications for all applications. Explore the full list and refine your search
General physiology and biophysics 44:259-274 PubMed40567070
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:9950 PubMed39550386
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 49:102076 PubMed39222611
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107212 PubMed38522513
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 20:554-567 PubMed38150082
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of general medicine 16:467-480 PubMed36760683
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:4374978 PubMed36035221
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 23:149 PubMed35350589
2022
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 17:453-462 PubMed35350839
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:839603 PubMed35311132
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com